Vanberra Signal

EpiQuest

Curated by Signal

Provider of an AI-based protein analysis software for drug development

Overview

Provider of an AI-based protein analysis software for drug development. The company has developed software that assists researchers in the process of protein analysis and sequence generation. The software uses algorithms to predict immunodominant epitopes that aids in the process of drug development, vaccine development, and more. The company provides peptide tools for comparative studies on protein, charge, and characteristics.

Key facts

Founded
2013

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • AI-powered platform for drug discovery and development

    Health TechnologyLondon, United Kingdom
  • Chronic pain management app

    Health TechnologyAlloa, United Kingdom
  • AI-powered tools for pregnancy ultrasound to enhance medical diagnoses

    Health TechnologyLondon, United Kingdom

About EpiQuest

What does EpiQuest do?

Provider of an AI-based protein analysis software for drug development.

Where is EpiQuest headquartered?

EpiQuest is headquartered in Southampton, United Kingdom.

When was EpiQuest founded?

EpiQuest was founded in 2013.

Which sector is EpiQuest in?

EpiQuest operates in Health Technology.

Who are EpiQuest's competitors?

Companies similar to EpiQuest include Benevolent, FibroMapp, and Fraiya.